doxifluridine has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukazawa, H; Hongu, Y; Ichihara, S; Shimizu, H; Suzuki, S | 1 |
| Ishitsuka, H; Kamiyama, T; Miwa, M; Nishimura, J | 1 |
2 other study(ies) available for doxifluridine and Carcinoma 256, Walker
| Article | Year |
|---|---|
Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.
Topics: Animals; Carcinoma 256, Walker; Female; Floxuridine; Fluorouracil; Male; Mice; Rats; Sarcoma 180; Tegafur; Tissue Distribution | 1980 |
[Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Floxuridine; Fluorouracil; Humans; Leukemia L1210; Leukemia P388; Mice; Neoplasms; Neoplasms, Experimental; Pentosyltransferases; Pyrimidine Phosphorylases; Rats; Sarcoma 180 | 1987 |